|
|
||||||||
Department of Renal and Urology Research, GlaxoSmithKline, King of Prussia, Pennsylania 19406
| |
ABSTRACT |
|---|
|
|
|---|
The renal microvasculature is an important component in the regulation of kidney function. Recent studies suggest that oxygen radicals can contribute to the modulation of renal cortical and medullary microvascular function under normal conditions as well as in pathophysiological conditions such as diabetes mellitus and hypertension. This review focuses on studies that indicate oxygen radicals can cause renal vasoconstriction, mediate the vasoconstriction of other agonists, and modulate nitric oxide-dependent actions in the normal kidney. Hypertension and diabetes mellitus are associated with oxidative stress. Recent investigations suggest that oxygen radicals may contribute to the enhanced renal vascular tone, increased sensitivity to vasoconstrictors, impaired endothelium-dependent vasodilation, and enhanced tubuloglomerular feedback found in these pathophysiological conditions.
nitric oxide; hypertension; diabetes; kidney; vasoconstriction; superoxide; antioxidants
| |
INTRODUCTION |
|---|
|
|
|---|
OXYGEN RADICALS have well-established roles in the physiology of signal transduction, cell growth, and inflammation and in the pathophysiology of cancer, aging, atherosclerosis, radiation injury, and ischemia-reperfusion injury (22). Fewer investigations have been conducted to elucidate the function of oxygen radicals in the kidney. In the past, these studies focused on reactive oxygen species in renal injury, including ischemic renal failure, transplant rejection, acute glomerulonephritis, and nephrotoxic drugs (3). There is now accumulating evidence, however, that oxygen radicals may participate in the regulation of the renal microvasculature not only during dysfunction but also under normal conditions. This review will first briefly discuss the generation, degradation, and targets of oxygen radicals. Second, the review will highlight the studies that suggest a role for oxygen radicals in the physiological regulation of the renal microvasculature. Finally, the roles of reactive oxygen species during renal microvascular dysfunction in diabetes mellitus and hypertension will be discussed.
| |
WHAT ARE OXYGEN RADICALS? |
|---|
|
|
|---|
Oxygen radicals are produced endogenously under normal conditions,
and the levels are increased under conditions of oxidative stress. The
most common oxygen radicals are superoxide
(O2
), hydrogen peroxide
(H2O2), and hydroxyl radical (OH
)
(14, 22). Whereas the anions superoxide and hydroxyl
radical are more reactive, H2O2, which does not
possess the chemical structure of a radical, is more membrane permeable.
Several enzymes located throughout the cell, including in the plasma
membrane, cytosol, mitochrondria, and peroxisomes, generate oxygen
radicals. Superoxide is produced during normal mitochondrial respiration and by NADH oxidase, NADPH oxidase, xanthine oxidase, cyclooxygenase, lipoxygenase, and cytochrome P-450. Under
conditions where tetrahydrobiopterin is limited, superoxide can also be
produced from nitric oxide synthase (NOS). Superoxide spontaneously
gains an electron to form H2O2; however, three
isoforms of superoxide dismutase (SOD) also catalyze this reaction.
Mn-SOD is located in mitochrondria, and two isoforms of Cu,Zn-SOD are
located either extracellularly or intracellularly. Because native SOD
is a large molecular weight molecule with limited membrane
permeability, several pharmacological agents have been developed
to mimic SOD including 2,2,6,6-tetramethyl-1-piperidinoxyl
(TEMPO), 4-hydroxy TEMPO (TEMPOL),
2-ethyl-2,5,5-trimethyl-3-oxazolidinoxyl, and Mn(III)tetrakis(4-benzoic
acid) porphyrin chloride. TEMPOL is a cyclic nitroxide that is
membrane permeable, metal independent, stable, and active both in vitro
and in vivo (27). Once produced, H2O2 can be scavenged to water by catalase or
by glutathione peroxidase in the presence of reduced glutathione.
Decomposition of H2O2 in the presence of a
trace metal such as Fe2+ produces hydroxyl radical, also
known as the Fenton reaction (see Fig.
1).
|
In addition to the endogenous enzyme antioxidants SOD, catalase, and glutathione peroxidase, there are also scavenging antioxidants and metal binding proteins that aid in the prevention of oxidative stress. The most common scavenging antioxidants include ascorbic acid (vitamin C), alpha-tocopherol (vitamin E), cartenoids, flavanoids, uric acid, bilirubin, and thiols. Ascorbic acid is a water-soluble antioxidant and a first line of defense in plasma to inhibit lipid peroxidation. Alpha-tocopherol and beta-carotene are lipid-soluble antioxidants that act synergistically to prevent lipid peroxidation in membranes and lipoproteins. Metal binding proteins are involved in reducing hydroxyl radical formation and include hemoglobin, myoglobin, transferrin, metallotheinein, ferritin, and ceruloplasmin. Another characteristic of TEMPOL is that in vitro it enhances the catalase mimic activity of metmyoglobin (MbFeIII), thus facilitating H2O2 dismutation (23). Overall, TEMPOL is a SOD mimetic that not only reduces the direct effects of superoxide, but also the superoxide-driven Fenton reaction that produces hydroxyl radical. In addition, TEMPOL increases H2O2 dismutation, but it is not a catalase mimetic per se.
The three main targets of oxygen radicals are lipids, proteins, and DNA. Extensive lipid peroxidation in biological membranes causes alteration in fluidity, decreased membrane potential, increased permeability to hydrogen and other ions, and eventual rupture of the cell. Oxidation of proteins changes their primary structure, including the overall charge, folding, and hydrophobicity. Oxidatively modified proteins are susceptible to increased aggregation and degradation. Oxygen radical-induced damage of DNA includes changes in both DNA structure and chemistry, with the result being strand breakage. Whether oxygen radicals attack these targets depends on the delicate balance between levels of reactive oxygen species vs. antioxidants. Under many conditions, an increase in oxygen radical formation signals the activation of antioxidant enzymes to aid in the increased metabolism necessary to achieve redox balance. However, when the amount of radicals produced exceeds the resources for metabolism, oxidative stress results.
| |
PHYSIOLOGICAL ROLES OF OXYGEN RADICALS IN THE RENAL MICROVASCULATURE |
|---|
|
|
|---|
Several investigations demonstrated various functions of reactive oxygen species in the peripheral vasculature, and these studies have been reviewed elsewhere (26, 33, 42). This review will focus exclusively on the reports of oxygen radicals in the renal cortical and medullary microcirculation. In the renal microvasculature, oxygen radicals cause vasoconstriction, mediate the vasoconstriction of other agonists, and modulate nitric oxide (NO)-dependent actions.
Oxygen radicals are renal vasoconstrictors. Depending on the vascular bed and oxygen radical, reactive oxygen species can cause either vasodilation or vasoconstriction (26, 33). Studies conducted thus far suggest that superoxide causes vasoconstriction in the renal cortical and medullary microcirculation. In isolated, perfused renal afferent arterioles, paraquat-induced superoxide production causes vasoconstriction that is inhibited by the SOD mimetic TEMPOL (37). However, TEMPOL alone had no affect on afferent arteriolar tone, suggesting that oxygen radicals do not participate in maintaining basal tone of in vitro microperfused rabbit afferent arterioles. Furthermore, microperfusion of TEMPOL into the efferent arteriole of Wistar-Kyoto (WKY) rats did not alter the stop-flow pressure at tubular perfusions of 0 or 40 nl/min (44), again indicating that oxygen radicals do not affect basal cortical microvascular tone. In contrast, TEMPOL infusion into the renal medullary interstitium markedly increases medullary blood flow in the anesthetized rat, and infusion of an inhibitor of SOD decreased medullary blood flow (46). In addition, Rhinehart and Pallone (32) recently showed that TEMPOL dilates preconstricted rat outer medullary descending vasa recta. These studies suggest that, unlike in the cortical microvasculature, superoxide does participate in maintaining basal tone of the renal medullary microcirculation.
This regional difference may be due to the greater capability of the renal outer medulla to produce oxygen radicals. Because the medulla has a lower PO2 than the cortex, oxygen radical formation under basal conditions appears to be increased in the deeper region of the kidney (46). The higher basal levels of oxygen radicals may participate in the regulation of renal medullary blood flow and water and electrolyte excretion under physiological conditions. Indeed, Zou et al. (46) demonstrated that in association with the selective decrease in medullary blood flow (no change in cortical blood flow) during interstitial infusion of an inhibitor of SOD, urine flow and sodium excretion decreased in anesthetized rats. In contrast, TEMPOL infusion under the same conditions increased medullary blood flow, urine flow, and sodium excretion. There are several potential sources of superoxide in the renal microcirculation. Immunocytochemistry, RT-PCR, or Western analysis has identified all subunits of the NADPH oxidase enzyme in the rat kidney (5, 13). Fluorescence spectrometry of renal tissue suggests that superoxide is produced by NADH oxidase > NADPH oxidase
mitochondrial respiration > xanthine
oxidase in the cortex and by NADH oxidase
mitochondrial
respiration > NADPH oxidase > xanthine oxidase in the outer
medulla (46). Although there are several possible sites
for oxygen radical generation in the cortical and medullary
microvasculature, NAD(P)H oxidase appears to be one of the major sources.
Oxygen radical-induced renal vasoconstriction could be mediated by both
direct and indirect means. Superoxide can increase intracellular
calcium concentrations in vascular smooth muscle cells and in
endothelial cells through several different mechanisms (26). 8-Isoprostane PGF2
, which is the
product of oxygen radical's nonenzymic attack on arachidonic acid,
causes preferential vasoconstriction of the preglomerular vasculature
principally through activation of a thromboxane A2
(TXA2) receptor (41). In addition, superoxide
may inhibit the release of a vasodilator or stimulate the production of
a vasoconstrictor. For example, superoxide inhibits prostacyclin
synthase activity, thereby blocking the production of PGI2
(48). Recently, Chen et al. (6) showed that
superoxide increases the production and renal vasoconstrictor actions of adenosine. Whether some or all of these mechanisms play a role in oxygen radical-induced vasoconstriction of the renal
microcirculation remains to be determined.
Oxygen radicals participate in stimulated renal vasoconstriction.
Because oxygen radicals are extracellular signaling molecules, they may
be important in mediating the actions of other renal vasoconstricting
agents. ANG II, TXA2, endothelin-1 (ET-1), and norepinephrine are powerful vasoconstrictors of the renal
microvasculature. Superoxide has been shown to be permissive in the
TXA2-induced vasoconstriction of in vitro microperfused
afferent arterioles (37). Scavenging of superoxide with
TEMPOL completely prevents the vasoconstriction induced by
TXA2 receptor activation with U-46,619
(10
10-10
6 M) or by ANG II
(10
10-10
6 M). In contrast, TEMPOL only
partially blocks afferent arteriolar vasoconstriction induced by ET-1
and norepinephrine. The renal afferent arteriolar vasoconstrictor
responses to higher doses of ET-1 (10
9 M) and
norepinephrine (10
6 M) are not blocked by scavenging of
superoxide (author's unpublished observations). Although the
physiological role of oxygen radicals as signaling molecules for
vasoconstriction in the normal kidney needs to be further elucidated,
studies in the peripheral vasculature in normal animals and humans have
shown similar effects. In the rat mesenteric microcirculation
(20) and aorta (19) and in the human forearm
(9), ANG II-induced vasoconstriction is significantly attenuated after treatment with SOD or vitamin C. On the other hand,
norepinephrine-induced vasoconstriction in the aorta, similar to that
in the renal afferent arteriole, is not significantly altered by SOD
(19).
Superoxide restricts NO-dependent action. Several studies suggest that the oxygen radical superoxide interacts with NO and thus limits its bioavailability. The affinity of NO for superoxide is so high that its rate of reaction is limited only by diffusion. Because superoxide effectively degrades NO to peroxynitrite, the biological activity of NO may be determined by the availability of superoxide. This superoxide-mediated quenching of NO-dependent action appears to have a physiological role in the renal microvasculature.
NO modulates the renal vasoconstriction caused by agonists such as ANG II, TXA2, and ET-1. Many studies indicate that these agents stimulate NO production, which then acts to buffer the vasoconstriction. However, it is unclear why this agonist-induced NO production does not overcome the vasoconstriction and result in a vasodilation. Studies using in vitro microperfused rabbit afferent arterioles suggest that superoxide limits the amount of NO-mediated buffering of TXA2-induced vasoconstriction (37). The vasoconstrictor response of afferent arterioles to U-46,619 is turned into a vasodilator response in the same vessels pretreated with TEMPOL. This vasodilator response to U-46,619 during TEMPOL is blocked in the vessels pretreated with the NOS inhibitor NG-nitro-L-arginine methyl ester (L-NAME). These data suggest that superoxide plays an important role in limiting the amount of NO buffering TXA2 receptor-stimulated vasoconstriction in renal afferent arterioles. Because studies in the peripheral vasculature have shown that ANG II and ET-1 can stimulate superoxide and NO, it seems possible that their interaction may be playing a role in the renal microvasculature response to ANG II and ET-1 also. In addition, recent reports indicate that superoxide limits the buffering capability of NO in tubuloglomerular feedback (TGF). Microperfusion of the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) into the lumen of the macula densa produces graded buffering of TGF, and microperfusion of TEMPOL into the efferent arteriole blunts the maximal TGF response of WKY rats (45). This study further demonstrated that the acute vasodilatory responses to SNAP are enhanced after simultaneous microperfusion of TEMPOL and suggests that superoxide and NO interact in the juxtaglomerular apparatus to modulate the TGF response under normal conditions. Whether oxygen radicals participate in the overall regulation of glomerular filtration rate through the modulation of TGF remains to be determined. Because oxygen radicals can alter TGF through stimulation of adenosine production (6) and through altering NO signaling at the macula densa, more studies are needed to address whether oxygen radicals contribute to the complex response to long-term alterations in salt intake. Because chronic changes in salt diet alter the activity of the renin-angiotensin system, NO system, and (directly or indirectly) the production of oxygen radicals, the overall renal hemodynamic response to changes in salt intake will be an integration of these components and remains to be determined. The role of superoxide in restricting NO-mediated vasodilation in the renal medulla is less clear. Using the NO fluorescent indicator 4,5-diaminofluoroscein, Rhinehart and Pallone (32) demonstrated that stimulation of NO with bradykinin is significantly enhanced by TEMPOL in isolated rat outer medullary descending vasa recta. However, Zou et al. (46) showed that the increase in renal medullary blood flow and sodium excretion during renal medullary interstitial infusion of TEMPOL was only partially blocked by L-NAME in anesthetized rats. The difference in these results highlights the need to further integrate isolated vessel experiments with in vivo studies to understand fully the role of oxygen radicals and antioxidants in the medullary microvasculature. In addition, studies demonstrate that NO modulates ANG II-induced vasoconstriction in the renal medulla (47). Whether superoxide restricts NO-mediated buffering of ANG II-induced vasoconstriction of the medullary vasculature still remains to be determined. Although studies investigating the roles of oxygen radicals in the physiological regulation of the renal microcirculation have only recently begun, it is evident that oxygen radicals have important direct and indirect actions in both the cortical and medullary microcirculation. Oxygen radicals directly constrict the renal microcirculation and indirectly affect renal vascular tone by mediating the effects of other vasoconstrictors, stimulating the production of vasoconstrictors, and modulating the actions of vasodilators such as NO. In addition, acute studies have shown that the tonic production of oxygen radicals in the medulla causes vasoconstriction, antidiuresis, and antinatriuresis; and thereby it may contribute to the control of medullary blood flow and overall fluid and electrolyte balance. Basal production of oxygen radicals in the cortex contributes to the TGF component in the control of glomerular filtration rate. It is clear that long-term studies are now needed to discern the important roles of oxygen radicals in the overall physiological regulation of renal hemodynamic and excretory function.| |
PATHOPHYSIOLOGICAL ROLES OF OXYGEN RADICALS IN THE RENAL MICROVASCULATURE |
|---|
|
|
|---|
Renal dysfunction is a central cause of hypertension and a common consequence of diabetes mellitus. These pathophysiological conditions set up a vicious cycle of repeated renal injury and are the two leading causes of end-stage renal failure in the United States. Oxidative stress is associated with both diabetes and hypertension in humans and in experimental animal models. Therefore, this section will focus on how oxygen radicals may play an important role in the pathophysiology of the renal microvasculature in diabetes mellitus and hypertension.
Oxygen radicals in diabetes mellitus. Endothelial dysfunction in peripheral and renal vessels is a common sequela of diabetes mellitus. Although not all reports agree, some observations indicate that the tonic influence of NO in the renal microvasculature is suppressed and contributes to the endothelial dysfunction in the early stages of insulin-dependent diabetes (2). Because superoxide rapidly scavenges NO, one possible explanation for the lack of NO influence under basal conditions in the diabetic renal microvasculature is excessive superoxide. Indeed, renal cortical tissue from diabetic rats has increased superoxide production (16). Ohishi and Carmines (30) demonstrated that the afferent and efferent arteriolar vasoconstrictor response to the NOS inhibitor N-nitro-L-arginine (L-NNA) is impaired in juxtamedullary nephrons of streptozotocin-diabetic rats. Treatment with SOD restored the vasoconstrictor response to L-NNA. Similarly, vasodilatory responses of isolated renal arteries to SOD in streptozotocin-diabetic rats were greater than in control rats (8). These studies indicate that increased superoxide reduces the modulation by NO of basal tone in renal microvessels in diabetes.
In addition to an impaired basal NO influence, the stimulation of NO-dependent vasodilation by a number of agonists is also impaired in diabetic kidneys and may be due to elevations in oxygen radicals. In in vitro microperfused afferent arterioles from insulin-dependent diabetic rabbits at 10 days, acetylcholine-induced vasodilation was impaired and restored toward control after acute treatment with TEMPOL (34). However, SOD treatment did not improve acetylcholine-induced vasodilation in renal arteries isolated from diabetic rats at 6 wk (8). The conflicting results may be due to the differences in the duration of diabetes, the vessels studied, or membrane permeability of the enzyme antioxidant. Since superoxide limits the buffering capability of NO during agonist-induced vasoconstriction in the renal cortical microcirculation under normal conditions, it seems possible that under conditions of oxidative stress, such as in diabetes mellitus, that the buffering capability of NO during agonist-induced vasoconstriction is decreased. Indeed, Schoonmaker et al. (38) showed that the renal afferent arteriolar responsiveness to ANG II is enhanced in juxtamedullary nephrons from diabetic rats and that L-NNA did not alter the response. However, treatment with SOD restored the ability of L-NNA to enhance the vascular response to ANG II. These data suggest that excess superoxide is responsible for the lack of NO buffering of ANG II-induced vasoconstriction of afferent arterioles in diabetes. The increased oxygen radicals in the diabetic renal microvasculature may be due to selective and time-dependent changes in antioxidant activities in the kidney. Changes in antioxidant enzyme activities were comprehensively evaluated in a longitudinal study of kidneys isolated from rats 0-6 wk after induction of diabetes (18). The study demonstrated that total and Cu,Zn-SOD activities were increased 1-6 wk after diabetes, but that Mn-SOD activity was not different from controls. Renal glutathione peroxidase activity is also increased during 1-6 wk of diabetes, but there is a biphasic response of renal catalase activity to diabetes. In the kidney, catalase activity was increased 1 wk after diabetes, returned to control, and was then decreased at 5-6 wk. The activity of scavenging antioxidants was also variable in diabetic kidneys. Craven et al. (7) reported that vitamin E but not vitamin C was decreased in renal cortex of rats after 2 mo of diabetes. However, there are conflicting reports of the antioxidant activities in glomeruli isolated from diabetic rats (16, 31, 40). Because several antioxidants exist in multiple cell types of the kidney, further studies are needed to identify which antioxidant activities are altered specifically in the renal microvasculature. Overall, what may be lacking in the diabetic renal microvasculature is the normal compensatory upregulation of key antioxidant enzymes and scavengers in the presence of an increase in oxygen radical production. The sources of increased oxygen radical formation in diabetes are similar to those found under normal conditions in the kidney but with the additional factor of glucose. As previously mentioned, ANG II stimulates superoxide formation through activation of NADPH oxidase, which is increased in the retina of the BBZ/Wor diabetic rat (12). In streptozotocin-diabetic rats, angiotensin-converting enzyme inhibition attenuates the oxidative stress in the kidney and decreases albuminuria (21). Together, these studies intimate that ANG II-induced oxygen radical formation may play a role in the oxidative stress of the diabetic renal microvasculature. Increasing evidence suggests, however, that hyperglycemia is a main source of oxygen radical formation in diabetes. Elevated plasma glucose concentrations can increase oxygen radical production through glucose autooxidation, the formation of advanced glycosylation end products, and metabolic stress. Increased glucose in the media of normal in vitro microperfused rabbit afferent arterioles significantly increases their sensitivity to ANG II and prevents L-NAME-induced potentiation of the vasoconstrictor response (1). Although several more studies are needed, these reports suggest that hyperglycemia and ANG II may be important sources of oxidative stress in the diabetic renal microvasculature.Oxygen radicals in hypertension. Oxidative stress in the vasculature has been associated with human essential hypertension and several hypertensive animal models, including the spontaneously hypertensive rat (SHR), spontaneously hypertensive stroke-prone rat, ANG II-induced hypertension, renovascular hypertension, Dahl salt-sensitive hypertension, lead-induced hypertension, cyclosporine-induced hypertension, preeclampsia, obesity-induced hypertension, and DOCA-salt hypertension (42). However, because norepinephrine-induced hypertension does not alter vascular production of oxygen radicals (25), high blood pressure per se does not appear to be associated with oxidative stress in the vasculature. Most studies indicate that antioxidant treatment lowers blood pressure and improves endothelial function in large conduit vessels. The few studies that have investigated oxygen radicals in the kidney in hypertension also suggest that increased oxygen radicals are important in the renal microvascular dysfunction in hypertension.
The SHR has increased blood pressure and renal vascular resistance and an enhanced TGF response. Acute and longer-term studies suggest that oxygen radicals may play an important role in these characteristics. The SOD mimetic TEMPOL normalizes the blood pressure, renal vascular resistance, and renal excretion of 8-iso-PGF2
in SHR
(35, 36). Furthermore, TEMPOL increases the basal luminal diameter of in vitro perfused afferent arterioles of juxtamedullary nephrons in SHR while having no affect in WKY (15). These
studies suggest that oxygen radicals may contribute to the increased
blood pressure and renal microvasculature resistance in the SHR.
One of the potential mechanisms for the acute reduction in blood
pressure and renal vascular resistance in SHR treated with antioxidants
is via enhancing NO action in the renal vasculature or in the
juxtaglomerular apparatus. Systemic inhibition of NO synthesis with
L-NAME blocks the acute antihypertensive actions of TEMPOL
in SHR (36). This study implies that NO-mediated
vasodilation may be restored after scavenging of oxygen radicals in the
SHR, but the renal vascular response was not determined. However,
Ichihara et al. (15) demonstrated that afferent arteriolar
vasoconstrictor responses to neuronal (n) NOS inhibition with
S-methyl-L-thiocitrulline or nonselective
inhibition of NOS with L-NNA are enhanced in arterioles pretreated with TEMPOL in SHR but not in WKY. Investigators also show
that while nNOS inhibition with 7-nitroindazole (7-NI) treatment enhances TGF in WKY, the response is not altered in SHR
(44). Microperfusion of TEMPOL restores the enhancing
effect of 7-NI on TGF in SHR to the level observed in WKY. These
studies indicate that NO-mediated action in the renal microvasculature
and juxtaglomerular apparatus is impaired in the SHR and that elevated
oxygen radicals contribute to the lack of NO function. Finally, in more
recent studies, Welch and Wilcox (43) showed that 2-wk
treatment with candesartan in SHR restored a normal TGF response to
7-NI, but had no affect on the response to 7-NI during TEMPOL
microperfusion. These data suggest that ANG II AT1 receptor
stimulation of oxygen radical formation in the juxtaglomerular
apparatus has an important role in elevating oxygen radicals and
thereby diminishing NO signaling in the juxtaglomerular apparatus of SHR.
The actions of oxygen radicals in the renal microcirculation in
hypertension may not be limited to the cortex. Dukacz et al. (11) demonstrated that the renal medullary blood flow
response to ANG II is enhanced in SHR compared with WKY. Intermedullary infusion of L-arginine abolished the enhanced response to
ANG II in SHR, and L-NAME infusion enhanced the response in
WKY. Ten-week treatment with the angiotensin-converting enzyme
inhibitor enalapril decreased the sensitivity of the renal
medullary circulation to ANG II in SHR. Because previous studies
showed that ANG II can stimulate oxygen radicals in the vasculature, it
is possible that the lack of NO buffering in the medullary circulation
of the SHR may be due to increased ANG II-induced oxygen radical formation.
ANG II-induced stimulation of oxygen radical formation, which can
diminish NO action, is not specific to the SHR. Nishiyama et al.
(29) demonstrated that the increased blood pressure and renal vascular resistance in ANG II-infused hypertensive rats were
ameliorated by TEMPOL. NOS inhibition markedly attenuated the
hemodynamic response to TEMPOL. These studies strongly implicate ANG II
as a major source of oxygen radical formation in ANG II-dependent or
ANG II-sensitive forms of hypertension.
Another possible mechanism for the renal protective actions of
antioxidants in hypertension is through a reduction in the immune and
inflammatory responses. Reactive oxygen species can act as signal
transduction messengers for several transcription factors including
nuclear factor (NF)-
B, which plays a critical role in the activation
of multiple genes that contribute to the inflammatory response and end
organ damage. ANG II-dependent hypertension (28) and
DOCA-salt hypertension (4) animal models have increased NF-
B activation in the kidney and renal monocyte/macrophage
infiltration. In association with a reduction in vascular oxygen
radical formation, TEMPOL also reduces the blood pressure and NF-
B
activation and monocyte/macrophage infiltration in the kidneys of
DOCA-salt hypertensive rats (4). In double (human
renin and angiotensinogen)-transgenic rats (28), a
reduction in renal NF-
B activation and
monocyte/macrophage infiltration also decreases blood pressure, renal
vascular injury, and albuminuria. Therefore, some of the renal
vascular damage in hypertension may be due to the proinflammatory
actions of oxygen radicals in the kidney.
| |
SUMMARY |
|---|
|
|
|---|
There are several factors that contribute to the regulation of
renal microvascular tone (see Fig. 2).
These include paracrine and autocrine factors, such as ANG II,
adenosine, hydroxytetraenoic acids, and epoxyeicosatrienoic acids,
which act on VSM cells to cause vasoconstriction or vasodilation. The
endothelium produces endothelial-derived constricting factors, namely
ET-1, TXA2, and PGF2
and endothelium-derived
relaxant factors, such as NO, PGI2, PGE2, and
endothelium-derived hyperpolarizing factor, all of which have specific
actions on renal microvascular tone. In addition, the renal nerves
through activation of
-receptors that cause vasoconstriction and
-receptors that stimulate renin release also affect renal
microvascular tone.
|
In addition to these sympathetic and cellular mechanisms, there are also intrinsic renal responses that regulate renal function through alterations in microvascular tone. These include the myogenic response that transduces changes in perfusion pressure into changes in afferent arteriolar tone and TGF that coordinates NaCl delivery to the macula densa with afferent arteriolar tone. All of these mechanisms are important in the regulation of renal microvascular tone, which has a direct impact on glomerular filtration rate and tubular reabsorption.
This review has briefly highlighted where oxygen radicals may play a role in the regulation of renal microvascular tone under normal conditions and during renal dysfunction. In particular, studies show that oxygen radicals can cause vasoconstriction and mediate the vasoconstriction of some, but not all, renal vasoconstrictors. Superoxide interacts with NO to limit its action, including its role in blunting TGF and agonist-induced vasoconstriction. In diabetes mellitus and in hypertension, oxygen radicals are increased and contribute to the enhanced renal cortical and medullary vascular tone, increased sensitivity to vasoconstrictors, impaired endothelium-dependent vasodilation, and enhanced TGF. However, there are several factors that are important in the regulation of renal microvascular tone, which is a major but not the sole component in the regulation of overall renal function. To understand completely the physiological and pathophysiological roles of oxygen radicals in the renal microvasculature and, more importantly, in total renal function, further investigation is needed.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: C. G. Schnackenberg, GlaxoSmithKline, Dept. of Renal and Urology Research, UW2521, Box 1539, 709 Swedeland Rd., King of Prussia, PA 19406 (E-mail: Christine_G_Schnackenberg{at}gsk.com).
10.1152/ajpregu.00605.2001
| |
REFERENCES |
|---|
|
|
|---|
1.
Arima, S,
Ito S,
Omata K,
Takeuchi K,
and
Abe K.
High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles.
Kidney Int
48:
683-689,
1995[ISI][Medline].
2.
Bank, N,
and
Aynedjian HS.
Role of EDRF (nitric oxide) in diabetic renal hyperfiltration.
Kidney Int
43:
1306-1312,
1993[ISI][Medline].
3.
Baud, L,
and
Ardaillou R.
Reactive oxygen species: production and role in the kidney.
Am J Physiol Renal Fluid Electrolyte Physiol
250:
F765-F776,
1986.
4.
Beswick, RA,
Zhang H,
Marable D,
Catravas JD,
Hill WD,
and
Webb RC.
Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response.
Hypertension
37:
781-786,
2001
5.
Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T,
Welch WJ, and Wilcox CS. Expression and cellular localization of
classic NADPH oxidase subunits in the SHR kidney. Hypertension
In press.
6.
Chen, YF,
Li PL,
and
Zou AP.
Oxidative stress enhances the production and actions of adenosine in the kidney.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R1808-R1816,
2001.
7.
Craven, PA,
Derubertis FR,
Kagan VE,
Melhem M,
and
Studer RK.
Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-
and glomerular size in diabetes.
J Am Soc Nephrol
8:
1405-1414,
1997[Abstract].
8.
Dai, F,
Diederich A,
Skopec J,
and
Diederich D.
Diabetes-induced endothelial dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals.
J Am Soc Nephrol
4:
1327-1336,
1993[Abstract].
9.
Diikhorst-Oei, LT,
Stroes ES,
Koomans HA,
and
Rabelink TJ.
Acute simultaneous stimulation of nitric oxide and oxygen radicals by angiotensin II in humans in vivo.
J Cardiovasc Pharmacol
33:
420-424,
1999[ISI][Medline].
10.
Duerrschmidt, N,
Wippich N,
Goettsch W,
Broemme HJ,
and
Morawietz H.
Endothelin-1 induces NAD(P)H oxidase in human endothelial cells.
Biochem Biophys Res Commun
269:
713-717,
2000[ISI][Medline].
11.
Dukacz, SA,
Feng MG,
Yang LF,
Lee RM,
and
Kline RL.
Abnormal renal medullary response to angiotensin II in SHR is corrected by long-term enalapril treatment.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R1076-R1084,
2001
12.
Ellis, EA,
Grant MB,
Murray FT,
Wachowski MB,
Guberski DL,
Kubilis PS,
and
Lutty GA.
Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat.
Free Radic Biol Med
24:
111-120,
1998[ISI][Medline].
13.
Geiszt, M,
Kopp JB,
Varnai P,
and
Leto TL.
Identification of renox, an NAD(P)H oxidase in kidney.
Proc Natl Acad Sci USA
97:
8010-8014,
2000
14.
Halliwell, B,
and
Gutteridge JMC
Methods in Enzymology. San Diego: Academic, 1990.
15.
Ichihara, A,
Hayashi M,
Hirota N,
and
Saruta T.
Superoxide inhibits neuronal nitric oxide synthase influences on afferent arterioles in spontaneously hypertensive rats.
Hypertension
37:
630-634,
2001
16.
Ishii, N,
Patel KP,
Lane PH,
Taylor T,
Bian K,
Murad F,
Pollock JS,
and
Carmines PK.
Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus.
J Am Soc Nephrol
12:
1630-1639,
2001
17.
Jaimes, EA,
Galceran JM,
and
Raij L.
Angiotensin II induces superoxide anion production by mesangial cells.
Kidney Int
54:
775-784,
1998[ISI][Medline].
18.
Kakkar, R,
Mantha SV,
Radhi J,
Prasad K,
and
Kalra J.
Antioxidant defense system in diabetic kidney: a time course study.
Life Sci
60:
667-679,
1997[ISI][Medline].
19.
Kawazoe, T,
Kosaka H,
Yoneyama H,
and
Hata Y.
Acute production of vascular superoxide by angiotensin II but not by catecholamines.
J Hypertens
18:
179-185,
2000[ISI][Medline].
20.
Kawazoe, T,
Kosaka H,
Yoneyama H,
and
Hata Y.
Involvement of superoxide in acute reaction of angiotensin II in mesenteric microcirculation.
Jpn J Physiol
49:
437-443,
1999[ISI][Medline].
21.
Kedziora-Kornatowska, KZ,
Luciak M,
and
Paszkowski J.
Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors.
IUBMB Life
49:
303-307,
2000[ISI][Medline].
22.
Knight, JA.
Free radicals: their history and current status in aging and disease.
Ann Clin Lab Sci
28:
331-346,
1998[Abstract].
23.
Krishna, MC,
Samuni A,
Taira J,
Goldstein S,
Mitchell JB,
and
Russo A.
Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism.
J Biol Chem
271:
26018-26025,
1996
24.
Lassegue, B,
Sorescu D,
Szocs K,
Yin Q,
Akers M,
Zhang Y,
Grant SL,
Lambeth JD,
and
Griendling KK.
Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.
Circ Res
88:
888-894,
2001
25.
Laursen, JB,
Rajagopalan S,
Galis Z,
Tarpey M,
Freeman BA,
and
Harrison DG.
Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension.
Circulation
95:
588-593,
1997
26.
Lounsbury, KM,
Hu Q,
and
Ziegelstein RC.
Calcium signaling and oxidant stress in the vasculature.
Free Radic Biol Med
28:
1362-1369,
2000[ISI][Medline].
27.
Mitchell, JB,
Samuni A,
Krishna MC,
DeGraff WG,
Ahn MS,
Samuni U,
and
Russo A.
Biologically active metal-independent superoxide dismutase mimics.
Biochemistry
29:
2802-2807,
1990[Medline].
28.
Muller, DN,
Dechend R,
Mervaala EM,
Park JK,
Schmidt F,
Fiebeler A,
Theuer J,
Breu V,
Ganten D,
Haller H,
and
Luft FC.
NF-
B inhibition ameliorates angiotensin II-induced inflammatory damage in rats.
Hypertension
35:
193-201,
2000
29.
Nishiyama, A,
Fukui T,
Fujisawa Y,
Rahman M,
Tian RX,
Kimura S,
and
Abe Y.
Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats.
Hypertension
37:
77-83,
2001
30.
Ohishi, K,
and
Carmines PK.
Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus.
J Am Soc Nephrol
5:
1559-1566,
1995[Abstract].
31.
Reddi, AS,
and
Bollineni JS.
Selenium-deficient diet induces renal oxidative stress and injury via TGF-
1 in normal and diabetic rats.
Kidney Int
59:
1342-1353,
2001[ISI][Medline].
32.
Rhinehart, KL,
and
Pallone TL.
Nitric oxide generation by isolated descending vasa recta.
Am J Physiol Heart Circ Physiol
281:
H316-H324,
2001
33.
Rubanyi, GM.
Vascular effects of oxygen-derived free radicals.
Free Radic Biol Med
4:
107-120,
1988[ISI][Medline].
34.
Schnackenberg, CG,
and
Wilcox CS.
The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes.
Kidney Int
59:
1859-1864,
2001[ISI][Medline].
35.
Schnackenberg, CS,
and
Wilcox CS.
Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F2
.
Hypertension
33:
424-428,
1999
36.
Schnackenberg, CG,
Welch WJ,
and
Wilcox CS.
Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide.
Hypertension
32:
59-64,
1998
37.
Schnackenberg, CG,
Welch WJ,
and
Wilcox CS.
TP receptor-mediated vasoconstriction in microperfused afferent arterioles: roles of O2
and NO.
Am J Physiol Renal Physiol
279:
F302-F308,
2000
38.
Schoonmaker, GC,
Fallet RW,
and
Carmines PK.
Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus.
Am J Physiol Renal Physiol
278:
F302-F309,
2000
39.
Sorescu, D,
Somers MJ,
Lassegue B,
Grant S,
Harrison DG,
and
Griendling KK.
Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells.
Free Radic Biol Med
30:
603-612,
2001[ISI][Medline].
40.
Tagami, S,
Kondo T,
Yoshida K,
Hirokawa J,
Ohtsuka Y,
and
Kawakami Y.
Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits.
Metabolism
41:
1053-1058,
1992[ISI][Medline].
41.
Takahashi, K,
Nammour TM,
Fukunaga M,
Ebert J,
Morrow JD,
Roberts LJ,
Hoover RL,
and
Badr KF.
Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2
, in the rat. Evidence for interaction with thromboxane A2 receptors.
J Clin Invest
90:
136-141,
1992.
42.
Touyz, RM.
Oxidative stress and vascular damage in hypertension.
Curr Hypertens Rept
2:
98-105,
2000[Medline].
43.
Welch, WJ,
and
Wilcox CS.
AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
Kidney Int
59:
1257-1263,
2001[ISI][Medline].
44.
Welch, WJ,
Tojo A,
and
Wilcox CS.
Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR.
Am J Physiol Renal Physiol
278:
F769-F776,
2000
45.
Wilcox, CS,
and
Welch WJ.
Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback.
Acta Physiol Scand
168:
119-124,
2000[ISI][Medline].
46.
Zou, AP,
Li N,
and
Cowley AW, Jr.
Production and actions of superoxide in the renal medulla.
Hypertension
37:
547-553,
2001
47.
Zou, AP,
Wu F,
and
Cowley AW, Jr.
Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation.
Hypertension
31:
271-276,
1998
48.
Zou, MH,
and
Ullrich V.
Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase.
FEBS Lett
382:
101-104,
1996[ISI][Medline].
This article has been cited by other articles:
![]() |
S. Efrati, S. Berman, G. B. Aharon, Y. Siman-Tov, Z. Averbukh, and J. Weissgarten Application of normobaric hyperoxia therapy for amelioration of haemorrhagic shock-induced acute renal failure Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2213 - 2222. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, H.-F. Bao, J. L. Self, D. C. Eaton, and M. N. Helms Aldosterone-induced increases in superoxide production counters nitric oxide inhibition of epithelial Na channel activity in A6 distal nephron cells Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1666 - F1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Meier, J. Rossert, P.-F. Plouin, and M. Burnier Atherosclerotic renovascular disease: beyond the renal artery stenosis Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1002 - 1006. [Full Text] [PDF] |
||||
![]() |
A. Just, A. J. M. Olson, C. L. Whitten, and W. J. Arendshorst Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H83 - H92. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, A. F. Chen, and D. H. Wang Enhanced oxidative stress in kidneys of salt-sensitive hypertension: role of sensory nerves Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3136 - H3143. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Palm, D. G. Buerk, P.-O. Carlsson, P. Hansell, and P. Liss Reduced Nitric Oxide Concentration in the Renal Cortex of Streptozotocin-Induced Diabetic Rats: Effects on Renal Oxygenation and Microcirculation Diabetes, November 1, 2005; 54(11): 3282 - 3287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Fellner and W. J. Arendshorst Angiotensin II, reactive oxygen species, and Ca2+ signaling in afferent arterioles Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1012 - F1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sharma, A. Cook, M. Smith, C. Valancius, and E. W. Inscho TGF-{beta} impairs renal autoregulation via generation of ROS Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1069 - F1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox and D. Gutterman Focus on oxidative stress in the cardiovascular and renal systems Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H3 - H6. [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Rhinehart, G. Solis, J. Pittner, W. Lee-Kwon, W. J. Welch, C. S. Wilcox, and T. L. Pallone Chronic ANG II infusion increases NO generation by rat descending vasa recta Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H29 - H36. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adler and H. Huang Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase Am J Physiol Renal Physiol, November 1, 2004; 287(5): F907 - F913. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, K. Rhinehart, W. Kwon, E. Weinman, and T. L. Pallone ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H773 - H781. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Chade, J. D. Krier, M. Rodriguez-Porcel, J. F. Breen, M. A. McKusick, A. Lerman, and L. O. Lerman Comparison of acute and chronic antioxidant interventions in experimental renovascular disease Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1079 - F1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rodriguez-Iturbe, N. D. Vaziri, J. Herrera-Acosta, and R. J. Johnson Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all Am J Physiol Renal Physiol, April 1, 2004; 286(4): F606 - F616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Haque and D. S. A. Majid Assessment of Renal Functional Phenotype in Mice Lacking gp91PHOX Subunit of NAD(P)H Oxidase Hypertension, February 1, 2004; 43(2): 335 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rodrigo, W. Passalacqua, J. Araya, M. Orellana, and G. Rivera Homocysteine and Essential Hypertension J. Clin. Pharmacol., December 1, 2003; 43(12): 1299 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
|